You are here: Home » Reuters » News
Business Standard

Takeda posts 55 percent jump in annual profit, beats estimates

Reuters  |  TOKYO 

TOKYO (Reuters) - Japan's Takeda Pharmaceutical Co Ltd reported on Monday a 55.1 percent jump in annual operating profit, buoyed by growing sales of bowel disease drug Entyvio and heartburn and ulcer drug Takecab. Operating profit came in at 241.8 billion yen ($2.21 billion) for the year ended March, versus 155.9 billion yen a year ago. That was above an average estimate of 235.4 billion yen from 11 analysts polled by Thomson Reuters I/B/E/S.For the current financial year, Takeda sees an operating profit of 201 billion yen. The earnings come days after it agreed to acquire London-listed Shire ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Mon, May 14 2018. 11:43 IST